• 1
    Bosch J, Pizcueta P, Feu F, Fernández M, García-Pagán JC. Pathophysiology of portal hypertension. Gastroenterol Clin North Am 1992; 21:114.
  • 2
    Pizcueta MP, Pique JM, Fernandez M, Bosch J, Rodes J, Whittle BJ, Moncada S. Modulation of the hyperdynamic circulation of cirrhotic rats by nitric oxide inhibition. Gastroenterology 1992; 103:19091915.
  • 3
    Fernández M, García-Pagán JC, Casadevall M, Bernadich C, Piera C, Whittle BJR, Piqué JM, et al. Evidence against a role for inducible nitric oxide synthase in the hyperdynamic circulation of portal-hypertensive rats. Gastroenterology 1995; 108:14871495.
  • 4
    Shah V, Wiest R, Garcia-Cardena G, Cadelina G, Groszmann RJ, Sessa WC. Hsp90 regulation of endothelial nitric oxide synthase contributes to vascular control in portal hypertension. Am J Physiol 1999; 277:G463G468.
  • 5
    Pizcueta MP, Pique JM, Bosch J, Whittle BJ, Moncada S. Effects of inhibiting nitric oxide biosynthesis on the systemic and splanchnic circulation of rats with portal hypertension. Br J Pharmacol 1992; 105:184190.
  • 6
    Lee FY, Albillos A, Colombato LA, Groszmann RJ. The role of nitric oxide in the vascular hyporesponsiveness to methoxamine in portal hypertensive rats. Hepatology 1992; 16:10431048.
  • 7
    Fernandez M, Bonkovsky HL. Increased heme oxygenase-1 gene expression in liver cells and splanchnic organs from portal hypertensive rats. Hepatology 1999; 29:16721679.
  • 8
    Pizcueta MP, García-Pagán JC, Fernández M, Casamitjana R, Bosch J, Rodés J. Glucagon hinders the effects of somatostatin on portal hypertension. A study in rats with partial portal vein ligation. Gastroenterology 1991; 101:17101715.
  • 9
    Benoit JN, Zimmerman B, Premen AJ, Go VL, Granger DN. Role of glucagon in splanchnic hyperemia of chronic portal hypertension. Am J Physiol 1986; 251:G674G677.
  • 10
    Schrier RW, Arroyo V, Bernardi M, Epstein M, Henriksen JH, Rodes J. Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis. Hepatology 1988; 8:11511157.
  • 11
    Luo B, Abrams GA, Fallon MB. Endothelin-1 in the rat bile duct ligation model of hepatopulmonary syndrome: correlation with pulmonary dysfunction. J Hepatol 1998; 29:571578.
  • 12
    Moller S, Bendtsen F, Henriksen JH. Splanichnic and systemic hemodynamic derangement in decompensated cirrhosis. Can J Gastroenterol 2001; 15:94106.
  • 13
    Sadoshima J, Izumo S. Molecular characterization of angiotensin II-induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts: a critical role of the AT1 receptor subtype. Circ Res 1993; 73:413423.
  • 14
    Ito H, Hirata Y, Hiroe M. Endothelin-1 induces hypertrophy with enhanced expression of muscle-specific genes in cultured neonatal rat cardiomyocytes. Circ Res 1991; 69:209215.
  • 15
    Pozzi M, Carugo S, Boari G, Pecci V, de Ceglia S, Maggiolini S, Bolla GB, et al. Evidence of functional and structural cardiac abnormalities in cirrhotic patients with and without ascites. Hepatology 1997; 26:11311137.
  • 16
    Lewis FL, Adair O, Rector WG. Arterial vasodilation is not the cause of increased cardiac output in cirrhosis. Gastroenterology 1992; 102:10241029.
  • 17
    Wong F, Liu P, Tobe S, Morali G, Blendis L. Central blood volume in cirrhosis: measurement with radionuclide angiography. Hepatology 1994; 19:312321.
  • 18
    Bernardi M, Rubboli A, Trevisani F, Cancellieri C, Ligabue A, Baraldini M, Gasbarrini G. Reduced cardiovascular responsiveness to exercise induced sympathoadrenergic stimulation in patients with cirrhosis. J Hepatol 1991; 12:207216.
  • 19
    Grose RD, Nolan J, Dillon JF, Errington M, Hannan WJ, Bouchier IAD, Hayes PC. Exercise-induced left ventricular dysfunction in alcoholic and non-alcoholic cirrhosis. J Hepatol 1995; 26:326332.
  • 20
    Lunzer MR, Manghani KK, Newman SP, Sherlock SP, Bernard AG, Ginsburg J. Impaired cardiovascular responsiveness in liver disease. Lancet 1975; 2:382385.
  • 21
    Donovan CL, Marcovitz PA, Punch JD, Bach DS, Brown KA, Lucey MR, Armstrong WF. Two-dimensional and dobutamine stress echocardiography in the preoperative assessment of patients with end-stage liver disease prior to orthotopic liver transplantation. Transplantation 1996; 61:11801188.
  • 22
    Fernández M, Pizcueta P, García-Pagán JC, Feu F, Cirera I, Bosch J, Rodés J. Effects of ritanserin, a selective and specific S2-serotoninergic antagonist, on portal pressure and splanchnic hemodynamics in rats with long-term bile duct ligation. Hepatology 1993; 18:389393.
  • 23
    Castañeda B, Debernardi-Venon W, Bandi JC, Andreu V, Pérez-del-Pulgar S, Moitinho E, Pizcueta P, et al. The role of portal pressure in the severity of bleeding in portal hypertensive rats. Hepatology 2000; 31:581586.
  • 24
    Garcia-Dorado D, Inserte J, Ruiz-Meana M, González MA, Solares J, Julià M, Barrabés JA, et al. Gap junction uncoupler heptanol prevents cell-to-cell progression of hypercontracture and limits necrosis during myocardial reperfusion. Circulation 1997; 96:35793586.
  • 25
    Poo JL, Jimenez W, Maria MR, Bosch-Marce M, Bordas N, Morales-Ruiz M, Perez M, et al. Chronic blockade of endothelin receptors in cirrhotic rats: hepatic and hemodynamic effects. Gastroenterology 1999; 116:161167.
  • 26
    Castro A, Jimenez W, Claria J, Ros J, Martinez JM, Bosch M, Arroyo V, et al. Impaired responsiveness to angiotensin II in experimental cirrhosis: role of nitric oxide. Hepatology 1993; 18:367372.
  • 27
    Schluter KD, Frischkopf K, Flesch M, Rosenkranz S, Taimor G, Piper HM. Central role for ornithine decarboxylase in β-adrenoceptor mediated hypertrophy. Cardiovasc Res 2000; 45:410417.
  • 28
    Agulló L, Garcia-Dorado G, Escalona N, Inserte J, Ruiz-Meana M, Barrabés JA, Mirabet M, et al. Hypoxia and acidosis impair cyclic GMP synthesis in coronary enthothelial cells. Am J Physiol 2002; 283:H917H925.
  • 29
    Kim S, Iwao H. Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases. Pharmacol Rev 2000; 52:1134.
  • 30
    Fallon MB, Abrams GA, McGrath JW, Hou Z, Luo B. Common bile duct ligation in the rat: a model of intrapulmonary vasodilatation and hepatopulmonary syndrome. Am J Physiol 1997; 272:G779G784.
  • 31
    Ma Z, Miyamoto A, Lee SS. Role of altered β-adrenoceptor signal transduction in the pathogenesis of cirrhotic cardiomyopathy in rats. Gastroenterology 1996; 110:11911198.
  • 32
    Battarbee HD, Zavecz JH. Cardiac performance in the portal vein-stenosed rat. Am J Physiol 1992; 263:G181G185.
  • 33
    Van Obbergh L, Vallieres Y, Blaise G. Cardiac modifications occurring in the ascitic rat with biliary cirrhosis are nitric oxide related. J Hepatol 1996; 24:747752.
  • 34
    Liu H, Ma Z, Lee SS. Contribution of nitric oxide to the pathogenesis of cirrhotic caridomyopathy in bile duct-ligated rats. Gastroenterology 2000; 118:937944.
  • 35
    Liu H, Song D, Lee SS. Increased nitric oxide synthase expression in aorta of cirrhotic rats. Life Sci 1999; 64:17531759.
  • 36
    Gadano AC, Sogni P, Heller J, Moreau R, Bories PN, Lebrec D. Vascular nitric oxide production during the development of two experimental models of portal hypertension. J Hepatol 1999; 30:896903.
  • 37
    Battarbee HD, Zavecz JH, Grisham MB, Maloney RE, Chandler LJ, Mercer JW, Cady FM. Cardiac impairment and nitric oxide synthase activity in the chronic portal vein-stenosed rat. Am J Physiol 1999; 276:G363G372.
  • 38
    Batkai S, Jarai Z, Wagner JA, Goparaju SK, Varga K, Liu J, Wang L, et al. Endocannabinoids acting at vascular CB1 receptors mediate the vasodilated state in advanced liver cirrhosis. Nat Med 2001; 7:827832.
  • 39
    Ros J, Claria J, To-Figueras J, Planaguma A, Cejudo-Martin P, Fernandez-Varo G, Martin-Ruiz R, et al. Endogenous cannabinoids: a new system involved in the homeostasis of arterial pressure in experimental cirrhosis in the rat. Gastroenterology 2002; 122:8593.
  • 40
    Ma Z, Lee SS. Cirrhotic cardiomyopathy: getting to the heart of the matter. Hepatology 1996; 24:451459.
  • 41
    Liu L, Zhang M, Luo B, Abrams GA, Fallon MB. Biliary cyst fluid from common bile duct-ligated rats stimulates endothelial nitric oxide synthase in pulmonary artery endothelial cells: a potential role in hepatopulmonary syndrome. Hepatology 2001; 33:722727.
  • 42
    Fort J, Pilette C, Oberti F, Veal N, Gallois Y, Douay O, Cales P. Long-term administration of PGE1 increases liver fibrosis and collateral blood flow in bile-duct-ligated rats. J Hepatol 1999; 30:7076.
  • 43
    Caramelo C, Fernández-Muñoz D, Santos JC, Blanchart A, Rodriguea-Puyol D, Lopez-Novoa JM, Hernando L. Effect of volume expansion hemodynamics, capillary permeability and renal function in concious, cirrhotic rats. Hepatology 1986; 6:129134.
  • 44
    Ruwhof C, van der Laarse A. Mechanical stress-induced cardiac hypertrophy: mechanisms and signal trasnduction pathways. Cardiovasc Res 2000; 47:2337.
  • 45
    Valeriano V, Funaro S, Lionetti R, Riggio O, Pulcinelli G, Fiore P, Masini A, et al. Modification of cardiac function in cirrhotic patients with and without ascites. Am J Gastroenterol 2000; 95:32003205.
    Direct Link: